Skip to main content

CITADEL ADVISORS LLC

Position in KRSA — Korsana Biosciences, Inc.

CIK 1423053 MIAMI, FL

Position in KRSA

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$202,705
+$174,401 QoQ
Shares Held
8,542
+227.4% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 21 holders
Holding Since
Sep 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KRSA Over Time

Shares Held

Position Value (USD)

Derivatives in KRSA

reported options exposure · as of Mar 31, 2023
CallValue
$80,637
CallShares
1,327
PutValue
$867
PutShares
14

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,966,449 across 435 Biotechnology names. KRSA ranks #317 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KRSA

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $202,705 59,795
2026-03-31 $28,304 18,261
2023-03-31 $867 2,000
2023-03-31 $80,637 185,800
2022-12-31 $1,574 2,400
2022-12-31 $163,212 248,800
2022-09-30 $9,159 10,651
2022-09-30 $208,721 242,700
2022-06-30 $132,034 240,500
2022-03-31 $158,729 143,000
2021-12-31 $61,575 35,800
2021-12-31 $335,055 194,800
2021-12-31 $160,190 93,134
2021-09-30 $225,288 73,384
2021-09-30 $482,910 157,300
2021-09-30 $164,551 53,600
2021-06-30 $394,679 101,200
2021-06-30 $352,142 90,293
2021-06-30 $239,069 61,300
2021-03-31 $56,915 20,400
2021-03-31 $39,690 14,226
2020-09-30 $71,743 11,800